Freeline Therapeutics Holdings plc Stock Split Ratio
Freeline Therapeutics Holdings plc reported Stock Split Ratio of 628.90% for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-04.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-04-04
- Freeline Therapeutics Holdings plc stockholders' equity note, stock split, conversion ratio for the quarter ending 2021-03-31 was 628.90%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|
| 2022-12-31 | 628.90% 20-F · filed 2023-04-04 | |||
| 2021-12-31 | 628.90% 20-F · filed 2023-04-04 | |||
| 2021-09-30 | 628.90% 6-K · filed 2021-11-09 | |||
| 2021-06-30 | 628.90% 6-K · filed 2021-08-16 | |||
| 2021-03-31 | 628.90% 6-K · filed 2021-05-17 | |||
| 2020-12-31 | 628.90% 20-F · filed 2023-04-04 |